Metraipolis › archive › dc_915be2002e82

US Food and Drug Administration black box warnings: Characteristics of drug classes and adverse effects — Europe PMC PMID:41935399

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41935399
DOI: 10.1016/j.jpet.2026.104317
License (as archived): solo-consultazione
Archived: 2026-11-04T09:07:47.207Z
SHA-256 of the archived text: 166c7332e4ff3cc10168a523a5a7c8c3b2b4b55979e1d7bea9f50f60e007ae11
Stable URL of this page: https://metraipolis.com/documento/dc_915be2002e82

How to cite

US Food and Drug Administration black box warnings: Characteristics of drug classes and adverse effects — Europe PMC PMID:41935399 — Europe PMC (en), https://europepmc.org/article/MED/41935399 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_915be2002e82 (Metraipolis archive dc_915be2002e82, sha256 166c7332e4ff3cc10168a523a5a7c8c3b2b4b55979e1d7bea9f50f60e007ae11)

BibTeX

@misc{dc915be2002e82,
  title = {US Food and Drug Administration black box warnings: Characteristics of drug classes and adverse effects — Europe PMC PMID:41935399},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41935399},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_915be2002e82; sha256 166c7332e4ff3cc10168a523a5a7c8c3b2b4b55979e1d7bea9f50f60e007ae11},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41935399. Agents can read the archived copy with the MCP tool read_document.